US biopharma PTC Therapeutics has entered into a financing collaboration with private equity group Blackstone so that it can achieve its goal of delivering at least one...
Sanofi has agreed a €300 million collaboration with private equity investor Blackstone Life Sciences (BXLS) to advance its innovative treatment for multiple myeloma (MM)...
As rumored earlier this month, private equity group Blackstone has emerged as the winning bidder for Takeda’s consumer healthcare business. The transaction is expected to...
Japanese pharma Takeda is apparently winding down the asset-shedding drive it launched following the $59 billion acquisition of Shire. The company is currently said to be...
14.04.2020
- Through a combination of equity and debt, private equity giant Blackstone will invest up to $2 billion in Cambridge, Massachusetts-based US biotech Alnylam Pharmaceuticals. The...
10.01.2018
- Following an in-depth investigation, EU antitrust officials have issued a statement of objections to the proposed acetate tow joint venture between Celanese and Blackstone. The...
20.10.2017
- Europe’s antitrust watchdog has opened an in-depth investigation into a proposed joint venture between Celanese and private equity group Blackstone over concerns it could hurt...
20.06.2017
- US chemical company Celanese and private equity group Blackstone are to combine their global acetate tow businesses. Celanese will own 70% of the joint venture, with Blackstone...
